Roggeri DP, Zanon E, Roggeri A. Recently approved recombinant factor VIII (rFVIII) for the replacement treatment in patients with hemophilia A in Italy. Farmeconomia. Health Economics and Therapeutic Pathways. 2017;18(1). https://doi.org/10.7175/fe.v18i1.1321